Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950123-20-006239
Filing Date
2020-06-12
Accepted
2020-06-12 18:22:25
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 42538
2 GRAPHIC g857852gra001.jpg GRAPHIC 9896
  Complete submission text file 0000950123-20-006239.txt   52035
Mailing Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2FX
Business Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2FX 44 (0)1438 906870
Freeline Therapeutics Holdings Ltd (Filer) CIK: 0001810031 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2836 Biological Products, (No Diagnostic Substances)